Basics Tempest Therapeutics, Inc. IPO Date: December 7, 2012 Sector: Healthcare Industry: Biotech Market Cap: $46.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 4.99% Avg Daily Range (30 D): $0.38 | 3.64% Avg Daily Range (90 D): $0.32 | 3.57% Institutional Daily Volume Avg Daily Volume: 1.09M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 211 Avg Trade Size (Sh.) (30 D): 89 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 58 Avg Inst. Trade: $1.06M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $.82M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.29M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 11.75K     News Sep 25, 2025 @ 5:00 PM Advanced Liver Cancer Clinical Trial Pipeline Show... Source: Delveinsight Feb 7, 2025 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A Jan 6, 2025 @ 1:00 PM Tempest Receives Orphan Drug Designation from the ... Source: N/A Dec 6, 2024 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A Sep 20, 2024 @ 8:30 PM Tempest Reports Inducement Grants Under Nasdaq Lis... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-5.95 $-2.07 $-3.16 Diluted EPS $-5.95 $-2.07 $-3.16 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -43.1M $ -7.87M $ -10.86M Operating Income / Loss $ -43.37M $ -7.97M $ -10.94M Cost of Revenue $ $ $ Net Cash Flow $ -.86M $ M $ M PE Ratio     Splits Apr 09, 2025:   1:13 Jun 28, 2021:   1:15